Literature DB >> 3553328

Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity.

I N Targoff, M Reichlin.   

Abstract

Antibody to the Jo-1 antigen (histidyl-tRNA synthetase) is found almost exclusively in myositis patients, usually those with adult PM, but has been found in only 30% of that group by immunodiffusion or other techniques thus far reported. We have reexamined the prevalence of antibody to Jo-1 in sera from 130 patients and 82 controls by using the sensitive ELISA technique. The ELISA used affinity-purified, enzymatically active bovine Jo-1 antigen. A wide range of antibody level by ELISA was found among 24 immunodiffusion positive sera. Six myositis and two control sera had apparent specific antibody detectable only by ELISA. Overall, however, the antibody continued to show high myositis specificity with predominance in adult PM (35.8% in that group). Because the antibody inhibits enzymatic activity of the synthetase antigen, we also studied the quantitative inhibitory activity of these sera to compare with the antibody activity as determined by ELISA. Twenty-four immunodiffusion-positive sera, 29 immunodiffusion-negative sera, and 15 normal sera were tested at 1/50 dilution in the reaction mixture. There was background inhibition by all normal sera tested that averaged 30.5%. All but one immunodiffusion negative myositis sera (a high binder by ELISA) inhibited less than 50% of the average with normal serum. Twenty-three of 24 immunodiffusion positive sera inhibited greater than 80% of this normal average; the other inhibited 66%. The serum dilution giving 50% inhibition was highly correlated (R = 0.83) with the ELISA activity. Thus, inhibition of histidyl-tRNA synthetase activity is a relatively accurate measure of Jo-1 antibody. This method should be applicable to measuring antibody to other aminoacyl-tRNA synthetases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553328

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  The role of autoantigens in the induction and maintenance of autoimmunity.

Authors:  P H Plotz
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

2.  Inflammatory myopathy, bronchiolitis obliterans/organizing pneumonia, and anti-Jo-1 antibodies--an interesting association.

Authors:  M Kalenian; B Zweiman
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

3.  Immunoaffinity purification and neutralization of scrapie prion infectivity.

Authors:  R Gabizon; M P McKinley; D Groth; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies.

Authors:  F W Miller; S A Twitty; T Biswas; P H Plotz
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.

Authors:  I N Targoff; E P Trieu; F W Miller
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

6.  Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.

Authors:  T Mozaffar; A Pestronk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

7.  The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity.

Authors:  F W Miller; K A Waite; T Biswas; P H Plotz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.

Authors:  Ayako Nakajima; Koichiro Yoshino; Makoto Soejima; Yasushi Kawaguchi; Takashi Satoh; Masataka Kuwana; Hisashi Yamanaka
Journal:  Rheumatol Int       Date:  2011-04-11       Impact factor: 2.631

9.  Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease.

Authors:  I N Targoff; F C Arnett; L Berman; C O'Brien; M Reichlin
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 10.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.